España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Nephros
NEPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.67
-0.03
-1.76%
At close: -
$1.67
0.00
0.00%
After Hours: Jan 28, 6:14 PM EDT
Get Report
Comment
Nephros (NEPH) Forecast
News
Earnings
Nephros (NEPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nephros (NASDAQ:NEPH) Stock
Nephros Stock (NASDAQ: NEPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Benchmark Reiterates Speculative Buy on Nephr...
Benzinga Newsdesk
Thursday, November 07, 2024
Nephros Q3 2024 GAAP EPS $0.02 Beats $(0.02) ...
Benzinga Newsdesk
Nephros Q3 Sales $3.50M Inline
Benzinga Newsdesk
Thursday, August 08, 2024
Nephros Q2 EPS $(0.03) Misses $(0.01) Estimat...
Benzinga Newsdesk
Friday, May 31, 2024
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Wednesday, May 15, 2024
Benchmark Reiterates Speculative Buy on Nephr...
Benzinga Newsdesk
Friday, May 10, 2024
Nephros Files For Mixed Shelf Of Up To $50M
Benzinga Newsdesk
Thursday, May 09, 2024
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04...
Benzinga Newsdesk
Friday, March 08, 2024
Benchmark Upgrades Nephros to Speculative Buy...
Benzinga Newsdesk
Thursday, March 07, 2024
Nephros: Q4 Earnings Insights
Benzinga Insights
Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0....
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
Earnings Outlook For Nephros
Benzinga Insights
Monday, February 26, 2024
11 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tuesday, December 26, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wednesday, December 13, 2023
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Tuesday, December 12, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Insiders Buying Delcath Systems And 3 Other Penny Stocks
Avi Kapoor
Wednesday, November 08, 2023
Nephros: Q3 Earnings Insights
Benzinga Insights
Nephros Q3 EPS $(0.02) Beats $(0.06) Estimate...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Wednesday, November 01, 2023
Nephros Names Judy Krandel As CFO, Effective ...
Benzinga Newsdesk
Tuesday, September 26, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, August 10, 2023
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, August 09, 2023
Nephros Q2 EPS $(0.04) Beats $(0.05) Estimate...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Wednesday, June 14, 2023
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, June 02, 2023
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, June 01, 2023
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Benzinga Insights
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, May 31, 2023
10 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Wednesday, May 10, 2023
Nephros: Q1 Earnings Insights
Benzinga Insights
Nephros Q1 EPS $(0.03) Misses $(0.02) Estimat...
Benzinga Newsdesk
Earnings Scheduled For May 10, 2023
Benzinga Insights
Monday, May 08, 2023
Nephros CEO Andy Astor To Retire, Robert Bank...
Benzinga Newsdesk
Thursday, April 06, 2023
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, April 04, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Nephros Sees Prelim. Q1 Revenue $3.7M, Up 69%...
Benzinga Newsdesk
Wednesday, March 08, 2023
Nephros Q4 EPS $(0.07) Misses $(0.06) Estimat...
Benzinga Newsdesk
Earnings Scheduled For March 8, 2023
Benzinga Insights
Tuesday, March 07, 2023
Nephros's Earnings: A Preview
Benzinga Insights
Wednesday, March 01, 2023
Nephros And Donastar Announce Strategic Partnership; Donastar Becomes Exclusive Master Distributor Of Nephros Commercial Water Filters For Food & Beverage And Hospitality Markets
Happy Mohamed
Wednesday, January 11, 2023
Nephros Foresees 6% Revenue Decline In Q4
Shivani Kumaresan
Nephros Reports Q4 Prelim. Sales Of ~$2.6M, F...
Benzinga Newsdesk
Friday, December 16, 2022
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Benzinga Insights
Wednesday, November 02, 2022
Nephros Q3 EPS $(0.12) Misses $(0.11) Estimat...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2022
Benzinga Insights
Tuesday, October 11, 2022
Nephros Sees Prelim. Revenues Of $2.5M For Quarter Ended Sept. 30 vs $2.83M Est.
Bill Haddad
Nephros Announces Agreement to Sell Pathogen Detection Systems Business; Terms Not Disclosed
Bill Haddad
Thursday, September 22, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Show More
